共 48 条
[1]
Mehta P(2020)COVID-19: consider cytokine storm syndromes and immunosuppression Lancet 395 1033-1034
[2]
McAuley DF(2003)High ferritin and low glycosylated ferritin may also be a marker of excessive macrophage activation J Rheumatol 30 1027-1028
[3]
Brown M(2011)How I treat hemophagocytic lymphohistiocytosis Blood 118 4041-4052
[4]
Lambotte O(2016)Performances of the H-score for diagnosis of hemophagocytic lymphohistiocytosis in adult and pediatric patients Am J Clin Pathol 145 862-870
[5]
Cacoub P(2012)Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases Clin Rheumatol 31 1223-1230
[6]
Costedoat N(2010)Histiocytic disorders: recent insights into pathophysiology and practical guidelines Biol Blood Marrow Transplant 16 S82-S89
[7]
Le Moel G(2020)Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality Int J Antimicrob Agents 55 105954-631
[8]
Amoura Z(2020)NLRP3 inflammasome—a key player in antiviral responses Front Immunol 11 211-e31
[9]
Piette JC(2020)Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): immunoinformatics approach J Med Virol 92 618-151
[10]
Jordan MB(2020)Antihypertensive drugs and risk of COVID-19? Lancet Respir Med 8 e30-543